Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.933 18 days ( -1.12 % )
Last Price $0.0900 -9.02 %
High/ Low $0.0900 - $0.0988 21.36%
Chg 7 Days 13.07 % $0.0796 $0.0900
Chg 30 Days 34.03 % $0.0672 $0.0900
Chg 12 mos -54.32 % $0.197 $0.0900
Trend - 3 mos 51.47 % Width: 35.22 %
Trend - 12 mos -54.23 % Width: 660.45 %
Pred. range - 3 mos $0.112 - $0.152 24.90 % - 68.90 %
Pred. range - 12 mos N/A - $0.0450 -100.00 % - -50.00 %
Short MA avg 3 mos Sell May 15, 2024 - 2 days
Long MA avg 3 mos Buy Apr 17, 2024 - 22 days
Short/Long MA avg 3 mos Buy Apr 22, 2024 - 19 days
Short MA avg 12 mos Buy Apr 18, 2024 - 21 days
Long MA avg 12 mos Buy Apr 12, 2024 - 25 days
Short/Long MA avg 12 mos Buy Mar 13, 2024 - 46 days
Pivot Short Sell May 14, 2024 - 3 days
Bollinger Buy Nov 30, -1 - N/A days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals. Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets N... AGNPF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT